Results 21 to 30 of about 1,880,763 (299)

TMEM123 a key player in immune surveillance of colorectal cancer

open access: yesFrontiers in Immunology, 2023
Colorectal cancer (CRC) is a leading cause of cancer-associated death. In the tumor site, the interplay between effector immune cells and cancer cells determines the balance between tumor elimination or outgrowth.
Elisa Pesce   +28 more
doaj   +1 more source

Tumor-infiltrating lymphocyte: features and prognosis of lymphocytes infiltration on colorectal cancer

open access: yes, 2023
Tumor-infiltrating lymphocytes (TILs) are vital elements of the tumor microenvironment (TME), and the anti-tumor activity of TILs on colorectal cancer (CRC) has been a topic of concern.
Miao Qin (724772)   +11 more
core   +1 more source

The biologic importance of tumor‐infiltrating lymphocytes [PDF]

open access: yesJournal of Cutaneous Pathology, 2010
Detailed pathologic analysis has delineated a close association between intratumoral CD 8+ cytotoxic T cells and favorable clinical outcomes in diverse cancers. Conversely, the presence at tumor sites of negative immune regulatory elements, such as FoxP 3+ T cells (Tregs) and PD‐1/PD‐L1 co‐stimulatory molecules, is closely associated with inferior ...
F Stephen, Hodi, Glenn, Dranoff
openaire   +2 more sources

WAYS TO ENHANCE LYMPHOCYTE TRAFFICKING INTO TUMORS AND FITNESS OF TUMOR INFILTRATING LYMPHOCYTES

open access: yesFrontiers in Oncology, 2013
The tumor is a hostile microenvironment for T lymphocytes. Indeed, irregular blood flow and endothelial cell (EC) anergy that characterize most solid tumors hamper leukocyte adhesion, extravasation and infiltration. In addition, hypoxia and reprogramming
Matteo eBellone   +2 more
doaj   +1 more source

Additional file 6 of High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs

open access: yes, 2022
Additional file6. Comparisons of tumor-infiltrating lymphocytes, platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio according to development of metastatic disease.
Hiroko Onagi (11626046)   +15 more
core   +1 more source

Breast cancer in Tanzanian, black American, and white American women: An assessment of prognostic and predictive features, including tumor infiltrating lymphocytes.

open access: yesPLoS ONE, 2019
IntroductionBreast cancer is a major cause of morbidity and mortality for women in Sub-Saharan Africa and for black American women. There is evidence that the pathologic characteristics of breast cancers in both African women and black American women may
Alex Mremi   +7 more
doaj   +1 more source

The expression of programmed death 1 in tumor-infiltrating lymphocytes of hepatocellular carcinoma and its correlation with prognosis

open access: yesZhongguo aizheng zazhi, 2021
Background and purpose: Programmed death 1 (PD-1) plays an important role in the regulation of peripheral immune tolerance. The expression of PD-1 in tumor-infiltrating lymphocytes of hepatocellular carcinoma (HCC) and the relationship between PD-1 ...
肖 锋   +4 more
doaj  

Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors

open access: yesBMC Medicine, 2021
Tumor-infiltrating lymphocyte (TIL) therapy is a type of adoptive cellular therapy by harvesting infiltrated lymphocytes from tumors, culturing and amplifying them in vitro and then infusing back to treat patients.
Shuhang Wang   +10 more
doaj   +1 more source

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma [PDF]

open access: yes, 2021
Effective treatment options are limited for patients with advanced (metastatic or unresectable) melanoma who progress after immune checkpoint inhibitors and targeted therapies.
Khushalani, NI   +104 more
core   +2 more sources

Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer [PDF]

open access: yes, 2013
Background: Regulatory T cells (Treg) expressing the transcription factor forkhead-box protein P3 (Foxp3) have been identified to counteract anti-tumor immune responses during tumor progression. Besides, Foxp3 presentation by cancer cells itself may also
Kim, Mia   +38 more
core   +2 more sources

Home - About - Disclaimer - Privacy